The clinicopathological association between high CCR5 expression and deeper invasion supports the findings of promoted cell invasion and upregulated MMP2 mRNA expression in the three ESCC cell lines by rhCCL3 treatment. This evidence concerns the gene CCR5 and esophageal squamous cell carcinoma.